Barclays PLC Praxis Precision Medicines, Inc. Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.8 - $4.98 $10,902 - $67,867	13,628 Added 129.31%	24,167 $19,000
Q4 2022 Feb 13, 2023	BUY	$1.88 - $36.45 $16,797 - $325,680	8,935 Added 557.04%	10,539 $25,000
Q3 2022 Nov 03, 2022	SELL	$2.5 - $37.95 $737 - $11,195	-295 Reduced 15.53%	1,604 $4,000
Q2 2022 Aug 12, 2022	SELL	$1.75 - $11.34 $6,322 - $40,971	-3,613 Reduced 65.55%	1,899 $5,000
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $56,277 - $111,838	5,512 New	5,512 $56,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.